Stockwatch

If you had invested ₹10,000 in Mankind Pharma in 2023

Worth at the close on 30 Oct 2026
₹17,432
+74.3% Gain of ₹7,432 over 3.5 years.
Invested
₹10,000
On
09 May 2023
Price then
₹1,430
Price now
₹2,493
Annualised
+17.3%
Multiple
1.74×
₹7,500₹10,000₹12,500₹15,000₹17,500₹20,0002023202420252026
Mankind Pharma NIFTY 50, same money same dates What you put in

Value of ₹10,000 invested on 09 May 2023, month by month.

Was that any good?

The same money, somewhere else

WhereWorth nowChange Against MANKIND
Mankind Pharma ₹17,432 +74.3% —
NIFTY 50 ₹12,621 +26.2% ₹4,811 more
Fixed deposit at 6.5% ₹12,448 +24.5% ₹4,984 more

The NIFTY 50 figure is the index itself over the same dates, which like this page counts price only and no dividends — so the two are measured the same way. The fixed deposit line assumes a steady 6.5% a year for the whole period. No bank held one rate that long: Indian deposit rates ran from around 9% in 2014 to about 5.5% in 2021. Treat it as a yardstick, not a record of what a deposit actually paid.

Year by year

YearChange
2026 +13.5%
2025 -23.7%
2024 +45.3%
2023 +51.8%

Mankind Pharma on the record

All-time high
₹2,998
23 Dec 2024
52-week range
₹1,910 – ₹2,642
Deepest fall
-35.7%
23 Dec 2024 to 23 Mar 2026
Market cap
₹1.03 L Cr

How this was worked out

₹10,000 at ₹1,430 a share buys 6.99 shares. Held to the close of 30 Oct 2026 at ₹2,493, those shares are worth ₹17,432. Dividends are not included, and neither are brokerage, taxes or charges — the real figure would differ on both counts.

Data covers 09 May 2023 to 30 Oct 2026 (865 trading days), from end-of-day NSE prices. This page is a record of what prices did. It is not advice, and nothing here is a recommendation to buy or sell — read the disclaimer.

Companies of a similar size